Home Biosciences
French tech company | Builders Republic
About
Biotech venture builder that co-founds and develops dedicated biotech companies addressing unmet medical needs — portfolio includes One Biosciences (single-cell molecular profiling for oncology), Sequantrix (anti-fibrotic drug discovery using multi-modal single-cell datasets), and Apikal Therapeutics. Ended day-to-day operations in January 2025.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Seed
- Founded
- 2019
- City
- PARIS
- Region
- IDF
- Tracked rounds
- 1
- Amount raised
- 15 M€ raised since 2020
Funding rounds
- Seed · 2021
Investors
Notes
Societe en activite : aucune procedure collective au greffe, augmentation de capital et modification de l'administration publiees le 26/11/2025, exercice 2024 depose le 27/07/2025. Le statut « Morte » precedent n'etait etaye par aucune source.